Mpox infection during pregnancy is associated with a high risk of adverse outcomes. New data confirm that there is a significant risk of fetal loss, especially in the first trimester. The infection can also lead to congenital infection in the child. These findings call for targeted prevention strategies. It is also necessary to introduce specific treatment procedures for pregnant women. The study was published in Nature Medicine on January 14, 2026.